GE HealthCare Technologies Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $20.6B | $19.7B | $19.6B | $18.3B | $17.6B |
| Gross profit | $8.2B | $8.2B | $7.9B | $7.2B | $7.2B |
| Selling, general & administrative | $4.2B | $4.3B | $4.3B | $3.6B | $3.6B |
| Research and development | $1.3B | $1.3B | $1.2B | $1.0B | $816.0M |
| Operating expenses | $5.5B | $5.6B | $5.5B | $4.7B | $4.4B |
| Operating income | $2.8B | $2.6B | $2.4B | $2.5B | $2.8B |
| Interest expense | $440.0M | $504.0M | $542.0M | $77.0M | $40.0M |
| Pretax income | $2.8B | $2.6B | $2.4B | $2.5B | $2.9B |
| Income tax expense | $614.0M | $531.0M | $743.0M | $563.0M | $600.0M |
| Net income | $2.1B | $2.0B | $1.6B | $1.9B | $2.2B |
| Balance Sheet | |||||
| Cash and equivalents | $4.5B | $2.9B | $2.5B | $1.4B | — |
| Current assets | $12.5B | $9.9B | $9.4B | $8.3B | — |
| Total assets | $36.9B | $33.1B | $32.5B | $27.5B | — |
| Current liabilities | $9.1B | $9.6B | $9.0B | $7.2B | — |
| Total liabilities | $26.3B | $24.4B | $25.1B | $17.9B | — |
| Total debt | $10.0B | $9.0B | $9.5B | $8.3B | — |
| Stockholders' equity | $10.4B | $8.4B | $7.1B | $9.4B | $16.7B |
| Cash Flow Statement | |||||
| Cash from operations | $2.0B | $2.0B | $2.1B | $2.1B | $1.6B |
| Depreciation and amortization | $287.0M | $268.0M | $248.0M | $228.0M | $225.0M |
| Stock-based compensation | $130.0M | $125.0M | $114.0M | $67.0M | $76.0M |
| Capital expenditure | $482.0M | $401.0M | $387.0M | $310.0M | $248.0M |
| Free cash flow | $1.5B | $1.6B | $1.7B | $1.8B | $1.4B |
| Dividends paid | $64.0M | $55.0M | $41.0M | $0 | $0 |
| Share repurchases | $200.0M | $0 | $0 | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 454.9M · Free float 99.7%
Annual filing data through FY ended December 31, 2025; float as of July 16, 2026.